Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory Signals

Coronavirus disease 2019 (COVID-19) has a wide spectrum of clinical manifestations. An elevation of liver damage markers has been observed in numerous cases, which could be related to the empirical use of potentially hepatotoxic drugs. The aim of this study was to describe the clinical and analytica...

Descripción completa

Detalles Bibliográficos
Autores principales: Delgado, Ana, Stewart, Stefan, Urroz, Mikel, Rodríguez, Amelia, Borobia, Alberto M., Akatbach-Bousaid, Ibtissam, González-Muñoz, Miguel, Ramírez, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509270/
https://www.ncbi.nlm.nih.gov/pubmed/34640458
http://dx.doi.org/10.3390/jcm10194432

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509270/
https://www.ncbi.nlm.nih.gov/pubmed/34640458
http://dx.doi.org/10.3390/jcm10194432

Ejemplares similares